Showing results (1-10 of 816) with videos related to
Sort By:
Pageof 82
Drug Safety|May 1, 1993
Minimising the risks of PUVA treatmentM C van Praag, L N Tseng, A M Mommaas, et al.Journal of Photochemistry and Photobiology. B, Biology|July 1, 1993
Determination of the photoprotective efficacy of a topical sunscreen against UVB-induced DNA damage in human epidermisM C van Praag, L Roza, B W Boom, et al.Journal of Dermatological Science|January 1, 1992
Presence and interpretation of vascular immune deposits in human skin: the value of direct immunofluorescenceB W Boom, A M Mommaas, B J VermeerArchives of Dermatology|September 1, 1991
Dysplastic nevi. Occurrence in first- and second-degree relatives of patients with 'sporadic' dysplastic nevus syndromeM B Crijns, J Vink, C L Van Hees, et al.Journal of the American Academy of Dermatology|March 1, 1993
PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancerM C van Praag, J N Bavinck, W Bergman, et al.The Journal of Investigative Dermatology|August 1, 1989
Complement-mediated endothelial cell damage in immune complex vasculitis of the skin: ultrastructural localization of the membrane attack complexB W Boom, M Mommaas, M R Daha, et al.The British Journal of Dermatology|August 1, 1995
Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patientsR C Beckers, A Brand, B J Vermeer, et al.The British Journal of Dermatology|April 1, 1988
Drug-induced pseudolymphomatous skin reactionsS H Kardaun, E Scheffer, B J VermeerClinical and Experimental Immunology|January 1, 1994
Long-term ultraviolet B-induced impairment of Langerhans cell function: an immunoelectron microscopic studyM C van Praag, A A Mulder, F H Claas, et al.Journal of Dermatological Science|July 1, 1991
Decreased expression of decay-accelerating factor on endothelial cells of immune complex-mediated vasculitic skin lesionsB W Boom, A M Mommaas, M R Daha, et al.Pageof 82